Enapotamab vedotin, 1mg*5

Enapotamab vedotin, 1mg*5

Praluzatamab ravtansine, 1mg*5

Praluzatamab ravtansine, 1mg*5

Praluzatamab ravtansine, 1mg

6.475,98 RON
SKU
SKM_D4039_1mg

Praluzatamab ravtansine (CX-2009) is a conditionally activated Probody drug conjugate (PDC) comprising an anti-CD166 mAbconjugated to DM4, with a protease-cleavable linker and a peptide mask that limits target engagement in normal tissue and circulation.

Mai multe informatii
Price 5.442,00 RON (preturile sunt fara TVA)
Description

Praluzatamab ravtansine (CX-2009) is a conditionally activated Probody drug conjugate (PDC) comprising an anti-CD166 mAbconjugated to DM4, with a protease-cleavable linker and a peptide mask that limits target engagement in normal tissue and circulation.